» Articles » PMID: 27413095

Diagnosis of Ebola Virus Disease: Past, Present, and Future

Overview
Specialty Microbiology
Date 2016 Jul 15
PMID 27413095
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Laboratory diagnosis of Ebola virus disease plays a critical role in outbreak response efforts; however, establishing safe and expeditious testing strategies for this high-biosafety-level pathogen in resource-poor environments remains extremely challenging. Since the discovery of Ebola virus in 1976 via traditional viral culture techniques and electron microscopy, diagnostic methodologies have trended toward faster, more accurate molecular assays. Importantly, technological advances have been paired with increasing efforts to support decentralized diagnostic testing capacity that can be deployed at or near the point of patient care. The unprecedented scope of the 2014-2015 West Africa Ebola epidemic spurred tremendous innovation in this arena, and a variety of new diagnostic platforms that have the potential both to immediately improve ongoing surveillance efforts in West Africa and to transform future outbreak responses have reached the field. In this review, we describe the evolution of Ebola virus disease diagnostic testing and efforts to deploy field diagnostic laboratories in prior outbreaks. We then explore the diagnostic challenges pervading the 2014-2015 epidemic and provide a comprehensive examination of novel diagnostic tests that are likely to address some of these challenges moving forward.

Citing Articles

Dengue: epidemiology, diagnosis methods, treatment options, and prevention strategies.

Kothari D, Patel N, Kumar Bishoyi A Arch Virol. 2025; 170(3):48.

PMID: 39915348 DOI: 10.1007/s00705-025-06235-3.


Spatial modeling and ecological suitability of Ebola virus disease in Africa.

Baluma Didier L, Jude L, Franck E, Wang H, Wang X PLoS One. 2024; 19(10):e0311936.

PMID: 39436951 PMC: 11495548. DOI: 10.1371/journal.pone.0311936.


National burden of Ebola virus disease in Democratic Republic of the Congo: the urgency to act.

Ahmad B, Sagide M, Ntamwinja S, Byiringiro E, Kihanduka E, Rugendabanga E Ann Med Surg (Lond). 2024; 86(8):4579-4585.

PMID: 39118744 PMC: 11305799. DOI: 10.1097/MS9.0000000000002213.


RNA Analysis Using Immunoassay Detection Format.

Astatke M, Tiburzi O, Connolly A, Robinson M Methods Mol Biol. 2024; 2822:175-186.

PMID: 38907919 DOI: 10.1007/978-1-0716-3918-4_13.


NASBA Coupled to Paper Microfluidics for RNA Detection.

Tiburzi O, Papadakis S, Gerasopoulos K, Astatke M Methods Mol Biol. 2024; 2822:51-64.

PMID: 38907911 DOI: 10.1007/978-1-0716-3918-4_5.


References
1.
Grolla A, Lucht A, Dick D, Strong J, Feldmann H . Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot. 2005; 98(3):205-9. View

2.
Carroll M, Matthews D, Hiscox J, Elmore M, Pollakis G, Rambaut A . Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa. Nature. 2015; 524(7563):97-101. PMC: 10601607. DOI: 10.1038/nature14594. View

3.
Li J, Duan H, Chen H, Ji Y, Zhang X, Rong Y . Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2015; 42:34-39. PMC: 7110900. DOI: 10.1016/j.ijid.2015.10.021. View

4.
Baize S, Leroy E, Georges-Courbot M, Capron M, Debre P, Fisher-Hoch S . Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med. 1999; 5(4):423-6. DOI: 10.1038/7422. View

5.
Weller S, Bailey D, Matthews S, Lumley S, Sweed A, Ready D . Evaluation of the Biofire FilmArray BioThreat-E Test (v2.5) for Rapid Identification of Ebola Virus Disease in Heat-Treated Blood Samples Obtained in Sierra Leone and the United Kingdom. J Clin Microbiol. 2015; 54(1):114-9. PMC: 4702715. DOI: 10.1128/JCM.02287-15. View